ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 115 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $857,000 | -2.9% | 110,000 | +15.8% | 1.04% | +102.9% |
| Q1 2022 | $883,000 | -41.0% | 95,000 | 0.0% | 0.51% | -48.4% |
| Q4 2021 | $1,497,000 | -20.4% | 95,000 | -9.6% | 1.00% | -27.4% |
| Q3 2021 | $1,881,000 | +65.6% | 105,100 | +43.9% | 1.37% | +74.6% |
| Q2 2021 | $1,136,000 | +688.9% | 73,056 | +630.6% | 0.78% | +946.7% |
| Q1 2021 | $144,000 | -66.5% | 10,000 | -54.3% | 0.08% | -78.9% |
| Q4 2020 | $430,000 | -78.6% | 21,900 | -85.9% | 0.36% | -82.8% |
| Q3 2020 | $2,009,000 | -8.1% | 155,000 | +3.3% | 2.06% | -13.1% |
| Q2 2020 | $2,186,000 | +133.5% | 150,000 | +36.4% | 2.37% | +41.0% |
| Q1 2020 | $936,000 | -35.3% | 110,000 | +25.2% | 1.68% | -30.7% |
| Q4 2019 | $1,447,000 | +70.8% | 87,873 | +46.5% | 2.42% | +185.4% |
| Q3 2019 | $847,000 | +68.4% | 60,000 | +140.0% | 0.85% | +24.7% |
| Q2 2019 | $503,000 | – | 25,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |